Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples